Our Global Presence
Our capabilities and experience are crucial, but what guides us matters most.
It’s our values, principles and processes that allow us to deliver meaningful ideas to people. But what really sets us apart is our ability to challenge convention and take an entrepreneurial approach to amplify meaningful outcomes.
MedTech Sectors
News & Media
IDE Group has announced that its purpose-built ophthalmic auto-injector, OKO™, has received AU$1,200,000 grant through the Targeted Translation Research Accelerator (TTRA) program for Diabetes and Cardiovascular Disease to advance the commercialisation of OKO™.
Implementing Human-Centered Design (HCD) in MedTech start-ups presents challenges. We explore three main obstacles in integrating HCD into product development and suggest strategies for improvement.
IDE Group has been at the forefront of medical innovation for over two decades, partnering closely with leading healthcare companies and emerging disruptors to bring groundbreaking products and businesses into the market.